Viva Biotech Holdings (VB0) — Working Capital to Net Assets Ratio
Viva Biotech Holdings (VB0) has a Working Capital to Net Assets ratio of 19.3% as of June 2025. Working capital of €754.42 Million (current assets of €1.75 Billion minus current liabilities of €991.68 Million) is measured against net assets of €3.91 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See defensive interval ratio of Viva Biotech Holdings to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Viva Biotech Holdings Working Capital to Net Assets (2016–2024)
This chart shows how Viva Biotech Holdings's Working Capital to Net Assets ratio has evolved across 9 annual periods from 2016 to 2024. As of June 2025, the ratio stands at 19.3%, reflecting working capital of €754.42 Million against net assets of €3.91 Billion EUR. For the complete balance sheet picture, see VB0 total asset value.
Annual Working Capital to Net Assets for Viva Biotech Holdings (2016–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Viva Biotech Holdings from 2016 to 2024, covering 9 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check Viva Biotech Holdings liquid asset ratio to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 19.7% | €749.94 Million | €3.82 Billion | €1.88 Billion | €1.13 Billion | ▲ +6.2 pp |
| 2023 | 13.5% | €496.74 Million | €3.69 Billion | €2.03 Billion | €1.53 Billion | ▲ +33.8 pp |
| 2022 | -20.4% | €-733.75 Million | €3.60 Billion | €1.94 Billion | €2.67 Billion | ▼ -47.4 pp |
| 2021 | 27.0% | €1.06 Billion | €3.91 Billion | €1.98 Billion | €926.60 Million | ▼ -42.6 pp |
| 2020 | 69.6% | €2.62 Billion | €3.76 Billion | €3.35 Billion | €735.67 Million | ▲ +12.2 pp |
| 2019 | 57.5% | €1.02 Billion | €1.78 Billion | €1.09 Billion | €72.96 Million | ▼ -21.6 pp |
| 2018 | 79.0% | €198.71 Million | €251.44 Million | €241.17 Million | €42.46 Million | ▲ +48.6 pp |
| 2017 | 30.4% | €46.46 Million | €152.76 Million | €83.45 Million | €36.99 Million | ▼ -33.4 pp |
| 2016 | 63.8% | €48.84 Million | €76.50 Million | €65.16 Million | €16.32 Million | — |